• A
  • |
  • A
  • Text size

AMA-WPS Meetings

AMA-Women Physicians Section
Interim Business Meeting
November 8, 2014
Hilton Anatole
Dallas, Texas

Registration

Please check back for registration details.

WPS Meeting Schedule

Please check back for meeting details.

Resolutions

The resolution deadline for the 2014 Interim Meeting of the AMA-WPS is August 25.

Resolution Guidelines

Resolutions must be submitted to the AMA-WPS by the announced deadline date.

Each resolution submitted to the AMA-WPS Assembly will result in either a directive for action by the Governing Council or a resolution to the AMA-HOD. With this process, the AMA-WPS welcomes resolutions that offer a clear directive to the Governing Council (e.g., work with AMA staff to integrate women physicians into AMA activities), resolutions that seek to create new AMA policy, or resolutions that seek to amend existing AMA policy. Resolutions that seek to create AMA-WPS projects that require additional resources will not be accepted. However, resolutions that ask the AMA-WPS to ask the AMA to implement a similar project will be accepted. The AMA-WPS will not accept for discussion any resolution that is identical to one submitted to the AMA-HOD. Rather, that item will be discussed in the AMA-HOD Handbook Review Session to determine official AMA-WPS action. Once a resolution is submitted to the AMA-HOD, or the Governing Council undertakes the desired action and reports back to the AMA-WPS membership, the adopted resolution will be sunset.

To ensure your resolution has the best chance for adoption, the AMA-WPS suggests that the following be taken into consideration:

  • Make certain that the proposed action benefits physicians and/or their patients, or women physician members in particular.
  • Review the AMA PolicyFinder to determine whether current policy already exists.
  • Make sure that the resolution’s title appropriately reflects the action for which the resolution calls.
  • Be certain that the whereas statements of the resolution clearly state the need for the action you are seeking in the RESOLVED statement.
  • The RESOLVED portion of the resolution must be a definitive statement that is able to stand alone.
  • If appropriate, indicate in the RESOLVED portion at which AMA-HOD meeting you’d like the resolution to be considered. Unless the resolution is of some urgency, it should wait until the following meeting so that it can be included in the delegates’ handbook and they can properly prepare to discuss it.
  • Include a fiscal note. AMA-WPS staff can assist with the development of fiscal information.

Hotel & Airline Information

Please check back for more information.

Previous Meeting Highlights

The AMA Women Physicians Section (WPS) hosted its business meeting and reception, which featured a talk by Margaret Mungherera, MD, President of the World Medical Association. Dr. Mungherera shared insights on issues surrounding gender violence and ways to improve health among youth, particularly in Uganda.

One of the 2013 recipients of the Joan F. Giambalvo Fund for the Advancement of Women, Rashmi Kudesia, MD, delivered a presentation during the AMA-WPS business meeting. Dr. Kudesia shared results from her study, "Reproductive Knowledge, Barriers, and Outcomes among Female U.S. Medical Students and Trainees."

The business meeting concluded with a review of the AMA-HOD Handbook and AMA-WPS items of business. The AMA-WPS Governing Council reviewed its positions on various items of business before the AMA House of Delegates that focus on issues of concern to women physicians, medical students and patients.

The AMA-WPS sponsored two resolutions that were considered at this meeting. Resolution 310, "Physician Reentry and Licensure," asks the AMA to encourage states that do not grant a full and unrestricted license to physicians undergoing reentry to develop a non-disciplinary category of licensure. Resolution 509, "Impact of Pharmaceutical Advertising on Women's Health," asks the AMA to urge the U.S. Food and Drug Administration (FDA) to assure that all direct-to-consumer advertising of pharmaceuticals includes information regarding differing effects and risks between the sexes. This resolution also requests that the AMA urge the FDA to assure that pharmaceutical advertising to health care professionals includes specifics on whether testing of drugs prescribed to both sexes has included sufficient numbers of women to assure safe use in this population and whether such testing has identified needs to modify dosages based on sex. Both resolutions were adopted as amended.